India expects minimal price changes for its pharma exports under new US tariffs, as punitive measures haven’t hit the sector ...

Indian equity markets react to Trump's tariffs, impacting sectors like pharma, gems, auto components, and IT services ...

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and ...

Although Trump’s tariffs do not directly target India’s $283 billion IT services sector, his retaliatory action has created ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

The direct impact of higher US tariffs on India looks fluid as of now and a mutually beneficial trade deal by the end of this ...

Commerce Minister Piyush Goyal recently sparked a debate by challenging India's startup ecosystem to move beyond delivery ...

At the core of Kotak Private’s vision for its next phase of growth is a deep commitment to offering highly personalised, tech ...

AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, to import ...

The tragic death of 24-year-old pharmacy intern Nallapu Naganjali, who attempted suicide on March 24, at KIMS Bollineni ...

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...

Shares of pharmaceutical companies on Friday tumbled more than 11% amid reports that the Trump administration will soon ...